Logo - springer
Slogan - springer

About Springer - Media - Press Releases | Springer to acquire BioMed Central Group

Berlin / London, 7 October 2008

Springer to acquire BioMed Central Group

Springer Science+Business Media has reached an agreement to acquire BioMed Central Group, the leading global open access publisher.

BMC
Springer Science+Business Media has reached an agreement to acquire BioMed Central Group, the leading global open access publisher.
BioMed Central was launched in May 2000 as an independent publishing house committed to providing free access to peer-reviewed research in the biological and medical sciences. BMC is the largest open access provider in the world with over 180 peer-reviewed journals.
BioMed Central’s flagship journals include Journal of Biology, BMC Biology, BMC Medicine, Malaria Journal, BMC Bioinformatics and Genome Biology. BioMed Central has revenues of approximately EUR 15 million per year. The company is based in London, with a second office in Liverpool, and has approximately 150 employees.
Derk Haank, CEO of Springer Science+Business Media said: “This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade. We have gained considerable positive experience since starting Springer Open Choice in 2004, and BioMed Central’s activities are complementary to what we are doing. Additionally, this acquisition strengthens Springer’s position in the life sciences and biomedicine, and will allow us to offer societies a greater range of publishing options.”
Matthew Cockerill, Publisher of BioMed Central said: “We are very excited about this new phase of BioMed Central's growth and development. Springer has been notable among the major STM publishers for its willingness to experiment with open access publishing. BioMed Central has demonstrated that the open access business model can work, and we look forward to continued rapid growth as part of Springer. The support of our authors, journal editors and institutional customers has been vital to BioMed Central's success and we will continue to focus on offering the best possible service to these groups."
Springer Science+Business Media is one of the world’s leading suppliers of scientific and specialist literature. It is the second-largest publisher of journals in the science, technology, and medicine (STM) sector, the largest publisher of STM books and the largest business-to-business publisher in the German-language area. The group publishes over 1,700 journals and more than 5,500 new books a year, as well as the largest STM eBook Collection worldwide, currently offering approximately 28,000 titles. In 2004, Springer launched Springer Open ChoiceTM, its open access offering for authors and institutions. Springer has operations in about 20 countries in Europe, the USA, and Asia, and some 5,000 employees. In 2007, it generated annual sales of around EUR 906 million.
BioMed Central is an STM publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse.
Contact:
Eric Merkel-Sobotta
Springer Science+Business Media
Tel +49 30 82 787 54 34